Compile Data Set for Download or QSAR
maximum 50k data
Found 295 of ic50 for UniProtKB: P06730
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617314(US11753403, Compound I-264)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617317(US11753403, Compound I-265)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617320(US11753403, Compound I-266)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617324(US11753403, Compound I-174)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617325(US11753403, Compound I-267)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617326(US11753403, Compound I-74)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617328(US11753403, Compound I-268)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617333(US11753403, Compound I-177)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617334(US11753403, Compound I-270)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617337(US11753403, Compound I-271)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617342(US11753403, Compound I-272)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617344(US11753403, Compound I-180)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617346(US11753403, Compound I-273)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617352(US11753403, Compound I-274)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617358(US11753403, Compound I-275)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617368(US11753403, Compound I-278)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617371(US11753403, Compound I-279)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617374(US11753403, Compound I-280)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617375(US11753403, Compound I-87)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617377(US11753403, Compound I-281)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617380(US11753403, Compound I-282)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617382(US11753403, Compound I-190)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617383(US11753403, Compound I-283)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617390(US11753403, Compound I-94)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617393(US11753403, Compound I-96)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617397(US11753403, Compound I-309)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617398(US11753403, Compound I-310)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617399(US11753403, Compound I-320)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617400(US11753403, Compound I-321)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617401(US11753403, Compound I-322)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617402(US11753403, Compound I-323)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617403(US11753403, Compound I-324)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617404(US11753403, Compound I-325)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617405(US11753403, Compound I-326)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617406(US11753403, Compound I-327)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617407(US11753403, Compound I-329)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617408(US11753403, Compound I-330)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617409(US11753403, Compound I-331)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617410(US11753403, Compound I-332)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617411(US11753403, Compound I-333)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM616977(US11753403, Compound I-1)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617018(US11753403, Compound I-2)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617058(US11753403, Compound I-3)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617098(US11753403, Compound I-100)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617104(US11753403, Compound I-101)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617106(US11753403, Compound I-6)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617107(US11753403, Compound I-103)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617109(US11753403, Compound I-7)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617110(US11753403, Compound I-104)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEukaryotic translation initiation factor 4E [28-217](Homo sapiens (Human))
Pic Therapeutics

US Patent
LigandPNGBDBM617119(US11753403, Compound I-107)
Affinity DataIC50: <1.00E+3nMAssay Description:Test compounds (3.43 mM stock in DMSO) were diluted 2-fold in series in DMSO (10 concentration points). Compound solutions (1.2 μl/well) were ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 295 total ) | Next | Last >>
Jump to: